These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25651492)

  • 1. Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.
    Park JH; Joo CK; Chung SK
    Cornea; 2015 Apr; 34(4):449-55. PubMed ID: 25651492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits.
    Yoo AR; Chung SK
    Cornea; 2014 Oct; 33(10):1088-94. PubMed ID: 25119962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
    Lee HS; Chung SK
    Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.
    Ko BY; Kim YS; Baek SG; Lee GW; Kim JM; Jean WS; Lee NS; Kang J
    Cornea; 2013 May; 32(5):689-95. PubMed ID: 23377751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of topical infliximab on corneal neovascularization in rabbits.
    Kim JW; Chung SK
    Cornea; 2013 Feb; 32(2):185-90. PubMed ID: 23146933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.
    Lee YK; Chung SK
    Cornea; 2013 Aug; 32(8):1142-8. PubMed ID: 23739149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization.
    Agarwal S; Angayarkanni N; Iyer G; Srinivasan B; Natarajan R; Charola S; Arumugam S; Padmanabhan P
    Cornea; 2014 Oct; 33(10):1016-21. PubMed ID: 25090164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
    Kang S; Chung SK
    Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Effect of Topical Aflibercept on Corneal Neovascularization in Rabbits.
    Park YR; Chung SK
    Cornea; 2015 Oct; 34(10):1303-7. PubMed ID: 26114826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.
    Hashemian MN; Z-Mehrjardi H; Moghimi S; Tahvildari M; Mojazi-Amiri H
    Ophthalmic Res; 2011; 46(1):50-4. PubMed ID: 21212709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI; Kim SW; Kim S; Kim T; Kim EK
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
    Koh CH; Lee HS; Chung SK
    Cornea; 2014 May; 33(5):527-32. PubMed ID: 24608256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subconjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization.
    Ozdemir O; Altintas O; Altintas L; Yildiz DK; Sener E; Caglar Y
    Can J Ophthalmol; 2013 Apr; 48(2):115-20. PubMed ID: 23561605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
    Papathanassiou M; Theodossiadis PG; Liarakos VS; Rouvas A; Giamarellos-Bourboulis EJ; Vergados IA
    Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of ranibizumab and bevacizumab on corneal neovascularization in rabbits.
    Kim EK; Kong SJ; Chung SK
    Cornea; 2014 Jan; 33(1):60-4. PubMed ID: 24240485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
    Avisar I; Weinberger D; Kremer I
    Curr Eye Res; 2010 Feb; 35(2):108-15. PubMed ID: 20136420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model.
    Öner V; Küçükerdönmez C; Akova YA; Çolak A; Karalezli A
    Ophthalmic Res; 2012; 48(3):118-23. PubMed ID: 22538642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Combined Photodynamic Therapy and Topical Bevacizumab Treatment on Corneal Neovascularization in Rabbits.
    Kim RY; Chung SK; Kim MS; Ra H
    Cornea; 2016 Dec; 35(12):1615-1620. PubMed ID: 27684458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bevacizumab on corneal neovascularization in experimental rabbit model.
    Ahmed A; Berati H; Nalan A; Aylin S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):730-6. PubMed ID: 19788671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.